1. Home
  2. ALK vs CORT Comparison

ALK vs CORT Comparison

Compare ALK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALK
  • CORT
  • Stock Information
  • Founded
  • ALK 1932
  • CORT 1998
  • Country
  • ALK United States
  • CORT United States
  • Employees
  • ALK N/A
  • CORT N/A
  • Industry
  • ALK Air Freight/Delivery Services
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALK Consumer Discretionary
  • CORT Health Care
  • Exchange
  • ALK Nasdaq
  • CORT Nasdaq
  • Market Cap
  • ALK 6.0B
  • CORT 8.1B
  • IPO Year
  • ALK N/A
  • CORT N/A
  • Fundamental
  • Price
  • ALK $50.90
  • CORT $71.68
  • Analyst Decision
  • ALK Strong Buy
  • CORT Strong Buy
  • Analyst Count
  • ALK 11
  • CORT 4
  • Target Price
  • ALK $66.73
  • CORT $142.00
  • AVG Volume (30 Days)
  • ALK 3.0M
  • CORT 1.4M
  • Earning Date
  • ALK 07-16-2025
  • CORT 05-05-2025
  • Dividend Yield
  • ALK N/A
  • CORT N/A
  • EPS Growth
  • ALK 48.41
  • CORT 8.36
  • EPS
  • ALK 2.83
  • CORT 1.14
  • Revenue
  • ALK $12,640,000,000.00
  • CORT $685,446,000.00
  • Revenue This Year
  • ALK $22.86
  • CORT $35.85
  • Revenue Next Year
  • ALK $6.91
  • CORT $35.22
  • P/E Ratio
  • ALK $17.98
  • CORT $62.77
  • Revenue Growth
  • ALK 20.82
  • CORT 30.93
  • 52 Week Low
  • ALK $32.62
  • CORT $28.04
  • 52 Week High
  • ALK $78.08
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • ALK 50.61
  • CORT 46.01
  • Support Level
  • ALK $51.17
  • CORT $74.34
  • Resistance Level
  • ALK $53.12
  • CORT $80.65
  • Average True Range (ATR)
  • ALK 1.61
  • CORT 3.81
  • MACD
  • ALK -0.16
  • CORT -0.19
  • Stochastic Oscillator
  • ALK 32.61
  • CORT 16.43

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: